Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Anna-Maria Hoffmann-Vold, Toby M. Maher, Edward E. Philpot, Ali Ashrafzadeh, Oliver Distler. Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review. ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020

Member's Comments

No comment yet.

Related content which might interest you: Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence Source: Eur Respir Rev, 27 (150) 180074; 10.1183/16000617.0074-2018 Year: 2018 Oxygen therapy for interstitial lung disease: a systematic review Source: Eur Respir Rev 2017; 26: 160080 Year: 2017 The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review Source: Eur Respir J 2015; 46: 1113-1130 Year: 2015 Interstitial lung disease in childhood. A clinical review Source: Eur Respir J 2004; 24: Suppl. 48, 624s Year: 2004 Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review Source: ERJ Open Res, 7 (4) 00441-2021; 10.1183/23120541.00441-2021 Year: 2021 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (144) 160125; 10.1183/16000617.0125-2016 Year: 2017 Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Drug induced interstitial lung disease: a systematic review Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review Source: Eur Respir J 2015; 46: 795-806 Year: 2015 Evidence-based consensus recommendations for the identification and management of interstitial lung disease in systemic sclerosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Safety and benefits of beta-blockers in chronic obstructive pulmonary disease: a review of current evidence and meta-analysis Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Pulmonary hypertension in COPD patients: a systematic review and meta-analysis Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Arm training in patients with chronic obstructive pulmonary disease: a systematic review Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions Year: 2009 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 Treatment of pulmonary hypertension associated with COPD: a systematic review Source: ERJ Open Res, 8 (1) 00348-2021; 10.1183/23120541.00348-2021 Year: 2022 Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review Source: Eur Respir Rev, 29 (157) 190158; 10.1183/16000617.0158-2019 Year: 2020 Physical activity and mortality risk in people with interstitial lung disease: a systematic review and meta-analysis Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients Year: 2021